Abstract
Pseudomonas aeruginosa is an opportunistic bacteria causing severe and life-threatening infections in individuals with weakened immune systems. P. aeruginosa forms antibiotic-resistant biofilms, rendering it challenging to treat; hence, alternate therapies are required to eliminate it. Treatment of infections using a combination of drugs is gaining momentum to combat drug-resistant pathogens, including P. aeruginosa. This study explores the synergistic effects of Thymol in combination with Ciprofloxacin, Amikacin and Colistin against planktonic cells and biofilm of P. aeruginosa. Thymol in combination with Ciprofloxacin yields the fractional inhibitory concentration index values 0.156 and 0.375 in P. aeruginosa strains, GC14 and ATCC 9027, respectively, highlighting a robust synergistic effect on both the planktonic and biofilm of P. aeruginosa. The results showed that Thymol (512 μg/mL) and Ciprofloxacin (0.125 μg/mL) were the most effective combination with 95 and 93.5% total biofilm inhibition in GC14 and PA27, respectively, compared to the Thymol (512 μg/mL) and Ciprofloxacin (0.125 μg/mL) alone. Our findings suggest that the combinations of Thymol and Ciprofloxacin may be a potential therapeutic strategy to address the issue of infections caused by P. aeruginosa biofilms.
Data Availability
The datasets generated and analysed during the current study are available from the corresponding author upon reasonable request.
References
Lyczak JB, Cannon CL, Pier GB (2000) Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect Jul 2(9):1051–1060. https://doi.org/10.1016/s1286-4579(00)01259-4
Olivares E, Badel-Berchoux S, Provot C, Prévost G, Bernardi T, Jehl F (2020) Clinical impact of antibiotics for the treatment of Pseudomonas aeruginosa biofilm infections. Front Microbiol. https://doi.org/10.3389/fmicb.2019.02894
Vetrivel A, Ramasamy M, Vetrivel P, Natchimuthu S, Arunachalam S, Kim GS et al (2021) Pseudomonas aeruginosa biofilm formation and its control. Biologics 3:312–336. https://doi.org/10.3390/biologics1030019
Wenzel RP, Edmond MB (2001) The impact of hospital-acquired bloodstream infections. Emerg Infect Dis 7(2):174–177. https://doi.org/10.3201/eid0702.010203
Kosztołowicz T, Metzler R, Wa̡sik S, Arabski M, (2020) Modelling experimentally measured of ciprofloxacin antibiotic diffusion in Pseudomonas aeruginosa biofilm formed in artificial sputum medium. PLoS ONE 15(12):e0243003. https://doi.org/10.1371/journal.pone.0243003
Thai T, Salisbury BH, Zito PM (2023) Ciprofloxacin. In: StatPearls. Treasure island (FL): statpearls. http://www.ncbi.nlm.nih.gov/books/NBK535454/
Anderl JN, Franklin MJ, Stewart PS (2000) Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 44(7):1818–1824. https://doi.org/10.1128/AAC.44.7.1818-1824.2000
Walters MC, Roe F, Bugnicourt A, Franklin MJ, Stewart PS (2003) Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 47(1):317–323. https://doi.org/10.1128/AAC.47.1.317-323.2003
Liu T, Kang J, Liu L (2021) Thymol as a critical component of Thymus vulgaris L. essential oil combats Pseudomonas aeruginosa by intercalating DNA and inactivating biofilm. LWT 136:110354. https://doi.org/10.1016/j.lwt.2020.110354
Tokam Kuaté CR, Bisso Ndezo B, Dzoyem JP (2021) Synergistic antibiofilm effect of thymol and piperine in combination with aminoglycosides antibiotics against four Salmonella enterica serovars. Evid Based Complement Alternat Med. https://doi.org/10.1155/2021/1567017
Ramirez MS, Tolmasky ME (2017) Amikacin: uses, resistance, and prospects for inhibition. Molecules 22(12):2267. https://doi.org/10.3390/molecules22122267
Ristuccia AM, Cunha BA (1985) An overview of amikacin. Ther Drug Monit 7(1):12–25. https://doi.org/10.1097/00007691-198503000-00003
Andrade FF, Silva D, Rodrigues A, Pina-Vaz C (2020) Colistin update on its mechanism of action and resistance, present and future challenges. Microorganisms 8(11):1716. https://doi.org/10.3390/microorganisms8111716
Nation RL, Li J (2009) Colistin in the 21st century. Curr Opin Infect Dis 22(6):535–43. https://doi.org/10.1097/QCO.0b013e328332e672
Tängdén T (2014) Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria. Ups J Med Sci 119(2):149–153. https://doi.org/10.3109/03009734.2014.899279
Worthington RJ, Melander C (2013) Combination approaches to combat multi-drug resistant bacteria. Trends Biotechnol 31(3):177–184. https://doi.org/10.1016/j.tibtech.2012.12.006
Wu X, Pan J, Wu Y, Xi X, Ma C, Wang L et al (2017) PSN-PC: A novel antimicrobial and anti-biofilm peptide from the skin secretion of Phyllomedusa camba with cytotoxicity on human lung cancer cell. Molecules 22(11):1896. https://doi.org/10.3390/molecules22111896
Stefanović OD (2017) Synergistic activity of antibiotics and bioactive plant extracts: a study against gram-positive and gram-negative bacteria. Bacterial pathogenesis and antibacterial control. Intech open https://www.intechopen.com/chapters/58045https://doi.org/10.5772/intechopen.72026
Mini M, Sreekantan AP, Manikandan AK, Mohanan AG, Khan S, Kumar P (2022) Efflux-mediated ciprofloxacin and cefixime resistance in Pseudomonas aeruginosa. Environ Exp Biol 20(2):113–7. https://doi.org/10.22364/eeb.20.11
Clinical & Laboratory Standards Institute (2023) M07: Dilution AST for aerobically grown bacteria - CLSI. https://clsi.org/standards/products/microbiology/documents/m07/
Schwalbe R, Steele-Moore L, Goodwin AC (2007) Antimicrobial susceptibility testing protocols. Taylor Francis. https://doi.org/10.1201/9781420014495
Petersen PJ, Labthavikul P, Jones CH, Bradford PA (2006) In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother 57(3):573–576. https://doi.org/10.1093/jac/dki477
Olajuyigbe OO, Afolayan AJ (2015) In vitro synergy and time-kill assessment of interaction between kanamycin and metronidazole against resistant bacteria. Trop J Pharm Res 14(5):837–843. https://doi.org/10.4314/tjpr.v14i5.14
Mini M, Jayakumar D, Kumar P (2023) In-silico and in-vitro assessment of the antibiofilm potential of azo dye, carmoisine against Pseudomonas aeruginosa. J Biomol Struct. https://doi.org/10.1080/07391102.2023.2237579
Mira P, Yeh P, Hall BG (2022) Estimating microbial population data from optical density. Plos One. https://doi.org/10.1371/journal.pone.0276040
Xu X, Xu L, Yuan G, Wang Y, Qu Y, Zhou M (2018) Synergistic combination of two antimicrobial agents closing each other’s mutant selection windows to prevent antimicrobial resistance. Sci Rep. https://doi.org/10.1038/s41598-018-25714-z
Lambert RJ, Skandamis PN, Coote PJ, Nychas GJ (2001) A study of the minimum inhibitory concentration and mode of action of oregano essential oil. Thymol and carvacrol. J Appl Microbiol 91(3):453–62. https://doi.org/10.1046/j.1365-2672.2001.01428.x
Baek MS, Chung ES, Jung DS, Ko KS (2020) Effect of colistin-based antibiotic combinations on the eradication of persister cells in Pseudomonas aeruginosa. J Antimicrob Chemother 75(4):917–24. https://doi.org/10.1093/jac/dkz552
Shariati A, Arshadi M, Khosrojerdi MA, Abedinzadeh M, Ganjalishahi M, Maleki A et al (2022) The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. Front Public Health 10:1025633. https://doi.org/10.3389/fpubh.2022.1025633
Xu J, Zhou F, Ji BP, Pei RS, Xu N (2008) The antibacterial mechanism of carvacrol and thymol against Escherichia coli. Lett Appl Microbiol 47(3):174–179. https://doi.org/10.1111/j.1472-765X.2008.02407
Liu Q, Niu H, Zhang W, Mu H, Sun C, Duan J (2015) Synergy among Thymol, eugenol, berberine, cinnamaldehyde and streptomycin against planktonic and biofilm-associated food-borne pathogens. Lett Appl Microbiol 60(5):421–430. https://doi.org/10.1111/lam.12401
de Castro RD, de Souza TMPA, Bezerra LMD, Ferreira GLS, de Brito Costa EMM, Cavalcanti AL (2015) Antifungal activity and mode of action of Thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study. BMC Complement Altern Med 15:417. https://doi.org/10.1186/s12906-015-0947-2
Madhusoodhanan A, Minsa M, Mohanan A, Kumar P (2022) Bacterial biofilm eradication and combating strategies. Asia Pac J Mol Biol Biotechnol 11:22–36. https://doi.org/10.35118/apjmbb.2022.030.1.03
El Abed S, Saad I, Latrache H, Ghizlane Z, Hind M, Remmal A (2011) Carvacrol and Thymol components inhibiting Pseudomonas aeruginosa adherence and biofilm formation. Afr J Microbiol Res 5:3229–3232. https://doi.org/10.5897/AJMR11.275
Gupta P, Chhibber S, Harjai K (2016) Subinhibitory concentration of ciprofloxacin targets quorum sensing system of Pseudomonas aeruginosa causing inhibition of biofilm formation & reduction of virulence. Indian J Med Res 143(5):643–651. https://doi.org/10.4103/0971-5916.187114
Ayaz M, Ullah F, Sadiq A, Ullah F, Ovais M, Ahmed J et al (2019) Synergistic interactions of phytochemicals with antimicrobial agents: Potential strategy to counteract drug resistance. Chem Biol Interact 308:294–303. https://doi.org/10.1016/j.cbi.2019.05.050
Acknowledgements
Research funding under the Performance Linked Encouragement for Academic Studies and Endeavour (PLEASE) scheme, Kerala Government, and Consolidation of University Research for Innovation and Excellence in Women Universities (CURIE), DST, New Delhi, is duly acknowledged. The University Grant Commission Junior Research Fellowships, awarded to Devi Jayakumar, Minsa Mini and Parvathi Vaikkathillam, are duly acknowledged.
Funding
This research was supported by Research funding under the Performance Linked Encouragement for Academic Studies and Endeavour (PLEASE) scheme, Kerala Government, and Consolidation of University Research for Innovation and Excellence in Women Universities (CURIE), DST, New Delhi.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest that could potentially influence the results and interpretations in this manuscript.
Ethical Approval
Ethical approval was granted by the institutional Ethics Committee as per order B6/ 2012/ 2021/ GCWT, dated 21/03/2022.
Consent for Publication
All authors listed in this manuscript provide their consent for publication of the research article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jayakumar, D., Mini, M., Kumar, P. et al. Synergistic Effect of Thymol–Ciprofloxacin Combination on Planktonic Cells and Biofilm of Pseudomonas aeruginosa. Curr Microbiol 81, 23 (2024). https://doi.org/10.1007/s00284-023-03546-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00284-023-03546-z